Jennifer Doudna

Jennifer Doudna
Christopher Michel · CC BY-SA 4.0 · source
Name	Jennifer Doudna
Birth date	1964
Birth place	Washington, D.C.
Nationality	United States
Fields	Biochemistry, Molecular biology, Genetics
Workplaces	University of California, Berkeley, Howard Hughes Medical Institute, Massachusetts Institute of Technology, Harvard University, University of Colorado Boulder
Alma mater	Pomona College, Harvard Medical School, Yale University
Known for	CRISPR–Cas9 genome editing
Awards	Nobel Prize in Chemistry, Breakthrough Prize in Life Sciences, Lasker Award

Jennifer Doudna is an American biochemist and molecular biologist noted for her co‑development of CRISPR–Cas9 gene editing. She is a professor and researcher whose work spans structural biology, RNA biochemistry, and genome engineering, and she has played a central role in debates involving biomedical research, bioethics, and policy. Her career connects multiple institutions and collaborations across the United States and Europe.

Early life and education

Doudna was born in Washington, D.C. and raised in Hawaii and on the Big Island, attending schools influenced by Pacific research communities and Honolulu scientific outreach; she later studied at Pomona College and pursued graduate studies at Harvard University with training in Biochemistry under mentors connected to institutions such as Massachusetts Institute of Technology and Stanford University. She completed doctoral research at Harvard University and conducted postdoctoral work at University of Colorado Boulder and collaborative structural biology laboratories associated with Yale University and Hunter College. During her formative years she interacted with researchers from labs affiliated with Cold Spring Harbor Laboratory, Salk Institute for Biological Studies, Howard Hughes Medical Institute, and investigators linked to National Institutes of Health initiatives.

Research and career

Doudna's laboratory at University of California, Berkeley and affiliated appointments with Howard Hughes Medical Institute advanced work in RNA structure and function, collaborating with groups at Massachusetts General Hospital, Broad Institute, University of California, San Francisco, and Stanford University School of Medicine. Her research employed techniques developed at facilities such as Argonne National Laboratory, Lawrence Berkeley National Laboratory, and cryo‑electron microscopy centers connected to European Molecular Biology Laboratory. She has coauthored papers with scientists from Max Planck Society, Institut Pasteur, McGill University, and University of Oxford, and contributed to consortia including those funded by the Gates Foundation, Wellcome Trust, and National Science Foundation.

CRISPR–Cas9 development and applications

Doudna's key work on the CRISPR–Cas9 system emerged from collaborations with scientists who had characterized adaptive immunity in bacteria, including researchers from University of Alicante, University of Copenhagen, ETH Zurich, University of Vienna, and University of Barcelona. Her structural and biochemical elucidation of guide RNA and Cas9 interactions paralleled studies from teams at Zhejiang University, Peking University, Seoul National University, University of Tokyo, and RIKEN. The translation of CRISPR technologies led to applications developed in partnership with biotechnology enterprises such as Editas Medicine, Intellia Therapeutics, CRISPR Therapeutics, Synthego, and companies spun out from University of California, Berkeley and University of California, San Francisco collaborations. Clinical and agricultural deployments tied into trials and projects at National Institutes of Health, Food and Drug Administration, European Medicines Agency, Bill & Melinda Gates Foundation, and initiatives with DuPont, Bayer, Syngenta, and research programs at Wageningen University & Research. The CRISPR–Cas9 platform informed work in genetic disease models at Children's Hospital Boston, Johns Hopkins Hospital, Mayo Clinic, Cleveland Clinic, and experimental therapies linked to Memorial Sloan Kettering Cancer Center.

Awards and honors

Doudna's recognition includes major prizes and memberships from institutions such as the Royal Society, National Academy of Sciences, American Academy of Arts and Sciences, American Philosophical Society, and awards including the Nobel Prize in Chemistry (shared), the Breakthrough Prize in Life Sciences, the Lasker–DeBakey Clinical Medical Research Award, the Japan Prize, the Gairdner Foundation International Award, the Wolf Prize, the Harvey Prize, the Princess of Asturias Award, and honors from organizations including American Association for the Advancement of Science, European Molecular Biology Organization, Academia Europaea, Royal Swedish Academy of Sciences, and national orders bestowed by governments such as France and Japan. She has delivered named lectures at venues like Smithsonian Institution, Royal Institution, Cold Spring Harbor Laboratory, Cambridge University, Oxford University, and Rockefeller University.

Ethical, legal, and societal issues

Doudna has engaged with policy debates alongside ethicists and institutions such as The Hastings Center, Nuffield Council on Bioethics, World Health Organization, National Academy of Medicine, National Academies of Sciences, Engineering, and Medicine, and advisory panels convened by European Commission and United Nations. She coorganized summits involving researchers from Harvard University, MIT, Stanford University, University of Cambridge, Karolinska Institute, and commentators from The Hastings Center and Pew Charitable Trusts to address germline modification, dual‑use research, and regulatory frameworks interacting with agencies like U.S. Food and Drug Administration and European Medicines Agency. Debates included perspectives from legal scholars at Yale Law School, Harvard Law School, Stanford Law School, and public interest groups such as Amnesty International and Human Rights Watch on human rights, access, and equity.

Personal life

Doudna has family ties and collaborations that intersect with academic networks at University of California, Berkeley, Lawrence Berkeley National Laboratory, and outreach initiatives with museums and educational partners such as Exploratorium, California Academy of Sciences, and Smithsonian Institution. She has been involved in mentorship programs linked to Gordon and Betty Moore Foundation, Howard Hughes Medical Institute, and graduate training at Harvard Medical School and University of California, Berkeley. Her public presence includes participation in forums hosted by TED Conferences, appearances on panels at World Economic Forum in Davos, and contributions to science communication efforts supported by National Public Radio, BBC, and major newspapers.

Category:American biochemists Category:Living people